Skip to main content
. 2015 Jan 11;30(3):401–409. doi: 10.1093/mutage/geu087

Figure 4.

Figure 4.

Lung mass incidence and multiplicity. (A) Lung mass multiplicity following in vivo treatment with AFB1 in all genotypes combined and ogg1 (+/+) mice (P > 0.05, Mann–Whitney U-test). (B) Lung mass incidence with respect to time in all ogg1 genotypes combined, ogg1 (+/+) mice, ogg1 (+/−) mice and ogg1 (−/−) mice (P > 0.05, Mantel–Cox test).